Free Trial

scPharmaceuticals (SCPH) News Today

scPharmaceuticals logo
$4.07
-0.08 (-1.93%)
(As of 11/1/2024 ET)
scPharmaceuticals Inc. stock logo
Rice Hall James & Associates LLC Increases Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)
Rice Hall James & Associates LLC raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 25.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 621,665 shares of the company's sto
TD Cowen Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)
Craig-Hallum Remains a Buy on scPharmaceuticals (SCPH)
scPharmaceuticals Inc. stock logo
Bank of Montreal Can Makes New $1.54 Million Investment in scPharmaceuticals Inc. (NASDAQ:SCPH)
Bank of Montreal Can purchased a new stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 351,806 shares of the company's stock
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) Sees Large Drop in Short Interest
scPharmaceuticals Inc. (NASDAQ:SCPH - Get Free Report) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 4,250,000 shares, a decline of 15.0% from the August 31st total of 5,000,000 shares. Based on an average daily volume of 264,000 shares, the short-interest ratio is currently 16.1 days.
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Bought by King Luther Capital Management Corp
King Luther Capital Management Corp grew its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 51.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,205,140 shares of the company'
scPharmaceuticals Inc. stock logo
Rice Hall James & Associates LLC Has $2.16 Million Stake in scPharmaceuticals Inc. (NASDAQ:SCPH)
Rice Hall James & Associates LLC increased its stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 76.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 497,227 shares of the company's stock after purchasing an additional 216,122 shares
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Bought by AIGH Capital Management LLC
AIGH Capital Management LLC lifted its holdings in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 3.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,504,365 shares of the company's st
scPharmaceuticals Inc. stock logo
Assenagon Asset Management S.A. Buys 52,870 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)
Assenagon Asset Management S.A. increased its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 266.7% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 72,692 shares of the company's stock after buying an additional 52,870 shares during
scPharmaceuticals Inc. stock logo
HC Wainwright Analysts Raise Earnings Estimates for scPharmaceuticals Inc. (NASDAQ:SCPH)
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Research analysts at HC Wainwright raised their Q3 2024 EPS estimates for scPharmaceuticals in a note issued to investors on Monday, August 19th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings of ($0.28) per sha
scPharmaceuticals Inc. stock logo
Q2 2024 EPS Estimates for scPharmaceuticals Inc. (NASDAQ:SCPH) Decreased by Leerink Partnrs
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Research analysts at Leerink Partnrs lowered their Q2 2024 earnings per share (EPS) estimates for shares of scPharmaceuticals in a note issued to investors on Monday, August 12th. Leerink Partnrs analyst R. Ruiz now expects that the company wil
scPharmaceuticals earnings preview: what to expect
Craig-Hallum Gives a Buy Rating to scPharmaceuticals (SCPH)
scPharmaceuticals Inc. stock logo
scPharmaceuticals (SCPH) to Release Earnings on Wednesday
scPharmaceuticals (NASDAQ:SCPH) will be releasing earnings after the market closes on Wednesday, August 14, Zacks reports.
scPharmaceuticals Inc. stock logo
Short Interest in scPharmaceuticals Inc. (NASDAQ:SCPH) Rises By 19.9%
scPharmaceuticals Inc. (NASDAQ:SCPH - Get Free Report) was the target of a large increase in short interest in June. As of June 15th, there was short interest totalling 5,780,000 shares, an increase of 19.9% from the May 31st total of 4,820,000 shares. Based on an average daily volume of 237,500 shares, the short-interest ratio is currently 24.3 days. Currently, 26.5% of the company's stock are short sold.
scPharmaceuticals Inc. stock logo
Rubric Capital Management LP Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH)
Rubric Capital Management LP lifted its stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 29.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,500,000 shares of the company's stock after buying an addit
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) is AIGH Capital Management LLC's 2nd Largest Position
AIGH Capital Management LLC lifted its position in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 40.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,106,795 shares of the company's stock after a
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by King Luther Capital Management Corp
King Luther Capital Management Corp raised its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 48.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,393,525 shares of the company's stock after buying an additi
scPharmaceuticals Inc. stock logo
scPharmaceuticals Inc. (NASDAQ:SCPH) is Worth Venture Partners LLC's 8th Largest Position
Worth Venture Partners LLC increased its stake in scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 42.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 771,344 shares of the
scPharmaceuticals Inc. stock logo
Q2 2024 EPS Estimates for scPharmaceuticals Inc. Lowered by Analyst (NASDAQ:SCPH)
scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) - Research analysts at HC Wainwright lowered their Q2 2024 EPS estimates for shares of scPharmaceuticals in a report released on Wednesday, May 15th. HC Wainwright analyst D. Tsao now forecasts that the company will post earnings per share of ($0
Furoscix Growth Prospects Anchor Buy Rating for scPharmaceuticals
Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.

Unlock the Secret to Earning Consistent Income from Stocks Under $30! (Ad)

Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!

👉 Yes, I Want the Free Report! 👈

SCPH Media Mentions By Week

SCPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SCPH
News Sentiment

0.00

0.41

Average
Medical
News Sentiment

SCPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SCPH Articles
This Week

1

2

SCPH Articles
Average Week

Get scPharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SCPH) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners